Page last updated: 2024-11-03

ag 1879 and Tauopathies

ag 1879 has been researched along with Tauopathies in 1 studies

3-(4-chlorophenyl)-1-(1,1-dimethylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine: Fyn kinase inhibitor

Tauopathies: Neurodegenerative disorders involving deposition of abnormal tau protein isoforms (TAU PROTEINS) in neurons and glial cells in the brain. Pathological aggregations of tau proteins are associated with mutation of the tau gene on chromosome 17 in patients with ALZHEIMER DISEASE; DEMENTIA; PARKINSONIAN DISORDERS; progressive supranuclear palsy (SUPRANUCLEAR PALSY, PROGRESSIVE); and corticobasal degeneration.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Xiong, Y1
Jing, XP1
Zhou, XW1
Wang, XL1
Yang, Y1
Sun, XY1
Qiu, M1
Cao, FY1
Lu, YM1
Liu, R1
Wang, JZ1

Other Studies

1 other study available for ag 1879 and Tauopathies

ArticleYear
Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation.
    Neurobiology of aging, 2013, Volume: 34, Issue:3

    Topics: Animals; Brain; Cell Line, Tumor; Humans; Mice; Mice, Transgenic; Neurons; Phosphorylation; Protein

2013